2-Aminoindane: Revision history

10 April 2016

• curprev 01:1901:19, 10 April 2016 >Oskykins m 10,094 bytes +2 Text replacement - "2AI" to "2-AI"

9 April 2016

• curprev 04:3704:37, 9 April 2016 >Josikins m 10,092 bytes +2 Text replacement - "NM2AI" to "NM-2-AI"

8 April 2016

• curprev 03:4203:42, 8 April 2016 >Oskykins m 10,090 bytes +1 Text replacement - "is currently thought to be a grey area compound within most parts of the world" to "is currently believed to be a grey area compound within most parts of the world"

6 April 2016

• curprev 14:2014:20, 6 April 2016 >Kaylee 10,089 bytes +91 →External links

23 March 2016

• curprev 01:4001:40, 23 March 2016 >Oskykins m 9,998 bytes +1 Text replacement - "After that it takes" to "After that, it takes"

16 March 2016

• curprev 21:5821:58, 16 March 2016 >Oskykins m 9,997 bytes +56 Text replacement - "==Toxicity and harm potential==" to "==Toxicity and harm potential== {{Main|Research chemicals#Toxicity and harm potential}}"

15 March 2016

• curprev 23:0323:03, 15 March 2016 >Oskykins m 9,941 bytes +1 Text replacement - "itself or using it sparingly" to "itself and using it sparingly"
• curprev 21:0821:08, 15 March 2016 >Oskykins m 9,940 bytes +107 Text replacement - "===Tolerance and addiction potential===" to "It is strongly recommended that one use harm reduction practices when using this drug. ===Tolerance and addiction potential==="
• curprev 20:2820:28, 15 March 2016 >Oskykins m 9,833 bytes 0 Text replacement - "community confirm that there do not seem to be" to "community suggest that there do not seem to be"
• curprev 20:1620:16, 15 March 2016 >Oskykins 9,833 bytes −1 →Dangerous interactions

13 March 2016

• curprev 21:2921:29, 13 March 2016 >Josikins 9,834 bytes −272 No edit summary
• curprev 21:2721:27, 13 March 2016 >Josikins 10,106 bytes −11 No edit summary
• curprev 21:2521:25, 13 March 2016 >Josikins m 10,117 bytes −1 Text replacement - "further consumption). " to "further consumption). "
• curprev 20:3520:35, 13 March 2016 >Josikins m 10,118 bytes −1 Text replacement - "all stimulantss" to "all stimulants"
• curprev 20:3220:32, 13 March 2016 >Josikins m 10,119 bytes 0 Text replacement - "cravings and withdrawal effects" to "cravings and withdrawal effects"
• curprev 20:3020:30, 13 March 2016 >Josikins m 10,119 bytes +27 Text replacement - "When addiction has developed, cravings may occur if a person suddenly stops their usage." to "When addiction has developed, cravings and withdrawal effects may occur if a person suddenly stops their usage."
• curprev 20:2720:27, 13 March 2016 >Josikins 10,092 bytes −575 →Withdrawal symptoms
• curprev 20:2720:27, 13 March 2016 >Josikins 10,667 bytes −19 →Withdrawal symptoms
• curprev 20:0020:00, 13 March 2016 >Josikins 10,686 bytes +594 →Tolerance and addiction potential
• curprev 19:3719:37, 13 March 2016 >Josikins m 10,092 bytes +32 Text replacement - "*'''Effect::Cognitive fatigue''' *'''Effect::Thought deceleration''' *'''Effect::Anxiety''' *'''Effect::Depression''' *'''Effect::Wakefulness'''" to "*'''Effect::Cognitive fatigue''' *'''Effect::Thought deceleration''' *'''Effect::Anxiety''' *'''Effect::Depression''' *'''Effect::Wakefulness''' *'''Effect::Irritability'''"

3 March 2016

• curprev 19:2619:26, 3 March 2016 >Oskykins m 10,060 bytes +4 Text replacement - "designer drug" to "designer drug"

2 March 2016

• curprev 19:5919:59, 2 March 2016 >Josikins 10,056 bytes +229 No edit summary

26 February 2016

• curprev 20:1620:16, 26 February 2016 >Kaylee 9,827 bytes +14 No edit summary
• curprev 20:1520:15, 26 February 2016 >Kaylee 9,813 bytes +21 No edit summary
• curprev 20:0920:09, 26 February 2016 >Kaylee 9,792 bytes +40 No edit summary
• curprev 20:0820:08, 26 February 2016 >Kaylee 9,752 bytes +47 No edit summary
• curprev 20:0720:07, 26 February 2016 >Kaylee m 9,705 bytes +15 Text replacement - "is currently a grey area compound within all parts of the world." to "is currently thought to be a grey area compound within most parts of the world."
• curprev 20:0020:00, 26 February 2016 >Kaylee m 9,690 bytes +29 Text replacement - "===Psychosis=== Abuse of compounds within the amphetamine" to "===Psychosis=== {{Main|Stimulant psychosis}} Abuse of compounds within the amphetamine"
• curprev 19:5719:57, 26 February 2016 >Kaylee 9,661 bytes −23 No edit summary
• curprev 19:5719:57, 26 February 2016 >Kaylee m 9,684 bytes +4 Text replacement - " based upon at least one trial, antipsychotic" to " based upon at least one trial, antipsychotic"
• curprev 19:5519:55, 26 February 2016 >Kaylee 9,680 bytes +470 No edit summary
• curprev 19:4619:46, 26 February 2016 >Kaylee 9,210 bytes +400 →Subjective effects
• curprev 19:3919:39, 26 February 2016 >Kaylee 8,810 bytes −177 →Subjective effects

21 February 2016

• curprev 11:0811:08, 21 February 2016 >Oskykins m 8,987 bytes +12 Text replacement - " research chemical " to " research chemical "

14 February 2016

• curprev 05:2105:21, 14 February 2016 >Oskykins m 8,975 bytes +26 Text replacement - "Independent research" to "[https://www.google.com/ Independent research]"

4 February 2016

• curprev 21:3221:32, 4 February 2016 >Oskykins m 8,949 bytes +21 Text replacement - "==See also==" to "==See also== *Responsible use"

20 January 2016

• curprev 05:1705:17, 20 January 2016 >Oskykins m 8,928 bytes +136 Text replacement - "suggests that there are no negative health effects attributed to simply trying this drug at low to moderate doses or using it very sparingly (but nothing can be completely guaranteed)." to "suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses or using it very sparingly (but nothing can be completely guaranteed). Independent research should always be done to ensure that a combination of two or more substa...

8 January 2016

• curprev 08:1908:19, 8 January 2016 >MDMQualone m 8,792 bytes +23 Undo revision 64574 by MDMQualone (talk)
• curprev 07:5807:58, 8 January 2016 >MDMQualone m 8,769 bytes −23 No edit summary
• curprev 05:3805:38, 8 January 2016 >MDMQualone m 8,792 bytes 0 No edit summary

20 December 2015

• curprev 00:1000:10, 20 December 2015 >Josikins m 8,792 bytes −1 Text replacement - "Category:Psychoactive substances" to "Category:Psychoactive substance"

13 November 2015

• curprev 09:1509:15, 13 November 2015 >Rhz 8,793 bytes +73 added link to summary sheet

4 November 2015

• curprev 18:5918:59, 4 November 2015 >Josikins 8,720 bytes −3 No edit summary

1 November 2015

• curprev 22:4522:45, 1 November 2015 >PJosepherum m 8,723 bytes −9 Text replacement - "{{Template:SubstanceBox" to "{{SubstanceBox"

26 October 2015

• curprev 19:5319:53, 26 October 2015 >PJosepherum m 8,732 bytes +9 Text replacement - "{{SubstanceBox/" to "{{Template:SubstanceBox/"

5 October 2015

• curprev 22:3622:36, 5 October 2015 >Rhz 8,723 bytes −2,077 →Dangerous interactions: template-ified

2 October 2015

• curprev 08:3308:33, 2 October 2015 >Oskykins 10,800 bytes −58 No edit summary
• curprev 07:4407:44, 2 October 2015 >Rhz 10,858 bytes −248 →General risk: combined entries for MAOIs, 2ct2 and 2ct7 into one
• curprev 07:4207:42, 2 October 2015 >Rhz 11,106 bytes −47 →General risk: removed second entry for cocaine

26 September 2015

• curprev 14:4514:45, 26 September 2015 >Oskykins m 11,153 bytes +102 Text replacement - "Although many drugs are safe on their own, they can become dangerous and even life-threatening when combined with other substances. The list below contains some common potentially dangerous combinations, but may not include all of them. Independent research should always be done to ensure that a combination of two or more substances is safe before consumption." to "Although many drugs are safe on their own, they can become dangerous and even life-threatening when combined...